Why Early Detection and Emerging Therapies Are Driving Esophageal Squamous Cell Carcinoma Growth
The global esophageal squamous cell carcinoma market was valued at USD 1.352 billion in 2024 and is projected to reach USD 3.205 billion by 2035, expanding from USD 1.462 billion in 2025 at an 8.16% CAGR from 2025 to 2035. North America leads personalized treatment adoption, while immunotherapy is the fastest-growing segment in Asia-Pacific over the forecast period. The market is being shaped...
0 Σχόλια 0 Μοιράστηκε 6 Views 0 Προεπισκόπηση